At the tumor site, mice consistently displayed high percentages of tumor-infiltrating CD8+ cells, elevated levels of IFNγ expression in effector CD4+ and CD8+ T cells, and a substantial loss of Tregs [283]. This evidence concerns the gene CD8A and neoplasm.